F MRI Nanotheranostics for Cancer Management: Progress and Prospects.

Yanan Li, Jing Cui, Chenlong Li, Huimin Zhou, Jun Chang, Omer Aras, Feifei An

Journal: ChemMedChem 2022;17(4):e202100701

PMID: 34951121

Abstract

Fluorine magnetic resonance imaging ( F MRI) is a promising imaging technique for cancer diagnosis because of its excellent soft tissue resolution and deep tissue penetration, as well as the inherent high natural abundance, almost no endogenous interference, quantitative analysis, and wide chemical shift range of the F nucleus. In recent years, scientists have synthesized various F MRI contrast agents. By further integrating a wide variety of nanomaterials and cutting-edge construction strategies, magnetically equivalent F atoms are super-loaded and maintain satisfactory relaxation efficiency to obtain high-intensity F MRI signals. In this review, the nuclear magnetic resonance principle underlying F MRI is first described. Then, the construction and performance of various fluorinated contrast agents are summarized. Finally, challenges and future prospects regarding the clinical translation of F MRI nanoprobes are considered. This review will provide strategic guidance and panoramic expectations for designing new cancer theranostic regimens and realizing their clinical translation.

© 2021 Wiley-VCH GmbH.

Address: College of Medical Imaging, Shanxi Medical University, Taiyuan, 030001, Shanxi, China.; College of Basic Medicine, Shanxi Medical University, Taiyuan, 030001, Shanxi, China.; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; School of Public Health, Health Science Center, Xi'an Jiaotong University, No.76 Yanta West Road, Xi'an, 710061, Shaanxi, China.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.